A method for the preparation of zolmitriptan or its pharmaceutically acceptable salts, comprising isolation of a crystalline salt of zolmitriptan, its optional re-purification and conversion to the substance of formula (III). Zolmitriptan hydrochloride in the crystalline state.
Liquid pharmaceutical compositions comprising a triptan compound and Xylitol
申请人:Almirall, S.A.
公开号:EP2198889A1
公开(公告)日:2010-06-23
An aqueous liquid pharmaceutical composition comprising a) at least one triptan compound, pharmaceutically acceptable salts or hydrates thereof, and b) xylitol.
一种水基液体药物组合物,包含 a) 至少一种三苯氧胺化合物、其药学上可接受的盐或水合物,以及 b) 木糖醇。
A METHOD FOR THE PREPARATION OF ZOLMITRIPTAN
申请人:Zentiva, k.s.
公开号:EP2118095B1
公开(公告)日:2010-11-03
LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING A TRIPTAN COMPOUND AND XYLITOL
申请人:Almirall S.A.
公开号:EP2367573A1
公开(公告)日:2011-09-28
[EN] A METHOD FOR THE PREPARATION OF ZOLMITRIPTAN<br/>[FR] PROCÉDÉ DE PRÉPARATION DE ZOLMITRIPTAN
申请人:ZENTIVA AS
公开号:WO2008104135A1
公开(公告)日:2008-09-04
[EN] A method for the preparation of zolmitriptan or its pharmaceutically acceptable salts, comprising isolation of a crystalline salt of zolmitriptan, its optional re-purification and conversion to the substance of formula (III). Zolmitriptan hydrochloride in the crystalline state. [FR] L'invention porte sur un procédé de préparation de zolmitriptan ou de ses sels pharmaceutiquement acceptables, lequel procédé comprend une étape d'isolement d'un sel cristallin de zolmitriptan, sa repurification facultative et sa conversion en la substance de la formule (III). L'invention concerne un hydrochlorure de zolmitriptan à l'état cristallin.